S. Trumpp-Kallmeyer

发表

Development of a binding model to protein tyrosine kinases for substituted pyrido[2,3-d]pyrimidine inhibitors.

C. Humblet, J. Rubin, H. D. Showalter, 1998, Journal of medicinal chemistry.

G‐Protein Coupled Receptors: Models, Mutagenesis, and Drug Design

C. Humblet, S. Trumpp-Kallmeyer, J. Bikker, 1998 .

G-Protein coupled receptors: models, mutagenesis, and drug design.

C. Humblet, S. Trumpp-Kallmeyer, J. Bikker, 1998, Journal of medicinal chemistry.

Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.

J Hoflack, S. Trumpp-Kallmeyer, J. Hoflack, 1992, Journal of medicinal chemistry.

Modeling of G-Protein-Coupled Receptors

Susanne Trumpp-Kallmeyer, Jan Hoflack, Marcel Hibert, 1994 .

Computer-aided active-site-directed modeling of the Herpes Simplex Virus 1 and human thymidine kinase

Gerd Folkers, Susanne Trumpp-Kallmeyer, Oliver Gutbrod, 1991, J. Comput. Aided Mol. Des..

Computer graphic study on models of the molybdenum cofactor of xanthine oxidase

Michael Krug, Gerd Folkers, Susanne Trumpp-Kallmeyer, 1987, J. Comput. Aided Mol. Des..

Modelling of the binding site of the human m1 muscarinic receptor: Experimental validation and refinement

Susanne Trumpp-Kallmeyer, Hélène Bourdon, Herman Schreuder, 1997, J. Comput. Aided Mol. Des..

Three-dimensional models of G-protein coupled receptors

Jan Hoflack, Marcel Hibert, S. Trumpp-Kallmeyer, 1993 .

Structure-activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptor.

W. Denny, H. D. Showalter, S. Trumpp-Kallmeyer, 1999, Journal of medicinal chemistry.

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor.

W. Denny, A. Doherty, A. Bridges, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases.

D. Boschelli, D. W. Fry, S. Trumpp-Kallmeyer, 2000, Journal of medicinal chemistry.

Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of binding.

W. Denny, D. W. Fry, H. D. Showalter, 1997, Journal of medicinal chemistry.

Modelling and modification of the binding site of endothelin and other receptors.

S. Trumpp-Kallmeyer, J. Hoflack, M. Hibert, 1993, European journal of pharmacology.

Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa).

S. Trumpp-Kallmeyer, M. Linschoten, P. Yu, 2004, Bioorganic & medicinal chemistry.

The Binding Site of Neuropeptide Vasopressin V1a Receptor

J Hoflack, S. Trumpp-Kallmeyer, B. Mouillac, 1995, The Journal of Biological Chemistry.

Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.

J Hoflack, S. Trumpp-Kallmeyer, J. Hoflack, 1991, Molecular pharmacology.

Three-dimensional models of gonado-thyrotropin hormone receptor transmembrane domain.

S. Trumpp-Kallmeyer, J. Bidart, J. Hoflack, 1993, Drug design and discovery.

This is not a G protein-coupled receptor.

S. Trumpp-Kallmeyer, J. Hoflack, M. Hibert, 1993, Trends in pharmacological sciences.

Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.

C. Humblet, V. Hruby, S. Trumpp-Kallmeyer, 1996, Drug design and discovery.

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.

J Hoflack, S. Trumpp-Kallmeyer, M. Manning, 1995, The EMBO journal.

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin

S. Trumpp-Kallmeyer, B. Mouillac, J. Hoflack, 1996, FEBS letters.

Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors.

S. Trumpp-Kallmeyer, B. Mouillac, J. Hoflack, 1995, Pharmaceutica acta Helvetiae.

Re-evaluation of bacteriorhodopsin as a model for G protein-coupled receptors.

J Hoflack, S. Trumpp-Kallmeyer, J. Hoflack, 1994, Trends in pharmacological sciences.

Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site.

C. Guenet, S. Trumpp-Kallmeyer, J. Gies, 1999, European journal of pharmacology.

Three-dimensional structure of G protein-coupled receptors: from speculations to facts

S. Trumpp-Kallmeyer, B. Mouillac, J. Hoflack, 1996 .

Functional architecture of vasopressin/oxytocin receptors.

J Hoflack, N. Cotte, S. Trumpp-Kallmeyer, 1999, Journal of receptor and signal transduction research.

Pyrido[2,3-d]pyrimidin-7-one Inhi-bitors of Cyclin-Dependent Kinases.

D. Boschelli, S. Trumpp-Kallmeyer, D. Mcnamara, 2001 .

Three-dimensional models of neuropeptide G-protein coupled receptors

S. Trumpp-Kallmeyer, J. Hoflack, M. Hibert, 1994, Neuropeptides.